Zoetis (ZTS) Net Income Growth (3y) (2015 - 2026)
Zoetis (ZTS) Net Income Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 51.28% |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | 2.94% |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | 4.50% |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | -24,368.79% |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | -16.26% |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 66.11% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | -17.90% |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | - |
| 10 | Vireo Growth | 10.64 Bn | 10.52 Bn | 59.30 Mn | -38.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.94% |
| Dec 31, 2025 | 9.44% |
| Sep 30, 2025 | 10.94% |
| Jun 30, 2025 | 10.72% |
| Mar 31, 2025 | 0.45% |
| Dec 31, 2024 | 12.05% |
| Sep 30, 2024 | 7.83% |
| Jun 30, 2024 | 6.89% |
| Mar 31, 2024 | 2.39% |
| Dec 31, 2023 | 13.47% |
| Sep 30, 2023 | 7.56% |
| Jun 30, 2023 | 21.24% |
| Mar 31, 2023 | 3.50% |
| Dec 31, 2022 | 6.20% |
| Sep 30, 2022 | 6.84% |
| Jun 30, 2022 | 12.55% |
| Mar 31, 2022 | 23.94% |
| Dec 31, 2021 | 6.18% |
| Sep 30, 2021 | 16.74% |
| Jun 30, 2021 | 10.18% |